INHALER CFC FREE with DOSE COUNTER MDI Glycopyrrolate IP 9 point 0 mcg and Formoterol Fumarate 4 po
Indian Army
KOLKATA, WEST BENGAL
Bid Publish Date
08-Jun-2026, 9:02 am
Bid End Date
29-Jun-2026, 9:00 am
EMD
₹5,605
Location
Progress
Quantity
190313
Category
Rifampicin 600 mg plus Tab INH 300mg Tab
Bid Type
Two Packet Bid
The Indian Army under the Department Of Military Affairs invites bids for a broad assortment of medicines and inhalation products, including Rifampicin combinations, inhalers (CFC-free with dose counters), bronchodilators, steroids, antihistamines, antibiotics, and excipients. The tender lists around 20 items with an EMD of ₹5,605 and a flexible quantity clause allowing up to a 50% quantity variation at contracted rates. The procurement requires adherence to BBQR specifications; bidders must upload a comprehensive brochure and compliance documents. Deliverables are expected to align with indigenous/foreign shelf-life stipulations and stock replacement rules. The bid evaluation hinges on technical compliance to BBQR and supplier capability, with a focus on indigenous drug shelf-life and post-issuance stock replacement.
20-item pharmaceutical and inhalation product list with specific drug names
EMD amount: ₹5,605
Option clause enabling up to 50% quantity variation
BBQR specification adherence; brochure uploaded under Compliance of BBQR
Indigenous products shelf life: 5/6 remaining; foreign: 2/3 remaining
Stock replacement: replace unconsumed stock before 3 months of expiry
No quotation of health supplements in lieu of medicines unless asked
Delivery schedule linked to last delivery Order Date; extended time calculations defined
50% quantity variation allowed at contract initiation and during currency
BBQR compliance mandatory with brochure and schedules
Shelf-life and stock replacement rules govern acceptance
EMD ₹5,605 and OEM documentation required for bid
Indigenous vs foreign shelf-life rules impact evaluation
Not specified in detail; BBQR terms indicate standard bid payment upon delivery per contract
Delivery period linked to last original delivery order date; option clause can extend time proportionally with minimum 30 days
Not explicitly stated; evaluated by CFA/TERMS COMMITTEE per BBQR terms
Owner/authorized bidders with OEM partnerships for listed medicines and inhalers
Demonstrated capability to supply BBQR-compliant pharmaceutical products
Financials showing adequate turnover and historical performance
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Item Category
Rifampicin 600 mg plus Tab INH 300mg Tab , Rifampicin 150mg Cap , Salmeterol 50 mcg plus fluticasone 250 mcg accuhaler of 60 doses , Symbicort Turbuhaler Budesonide 320 mcg plus formoterol 9ug , Symbicort Turbuhaler Budesonide 160 mcg plus formoterol 4.5ug , RespiCaps Glycopyrronium Bromide USP equivalent to Glycopyrronium 25 mcg and Formoterol Fumarate Dihydrate IP equivalent to Formoterol Fumarate 12mcg and Excipients q.s , Levosalbutamol Respules 0.31mg , Budesonide 1 mg Respules. , Tab Bilastin 20 mg plus montelukast 10 mg , Tab levonadifloxacin 500 mg , Fluticasone Furoate 100 Mcg, Umeclidinium 62.5 Mcg and amp Vilanterol 25 mcg Inhaler Powder , INHALER CFC FREE with DOSE COUNTER MDI Glycopyrrolate IP 9.0mcg and Formoterol Fumarate 4.8mcg and Budesonide IP 160 mcg , Tab Montelukast 10 mg , Lignocaine HCl 2 percentage without Adrenaline 30 ml Inj suitable for ophthalmic use also , N-Acetyl Cysteine 200 mg per ml, 5 ml Ampoule , Urokinase 5 lacs unit plus diluent Inj , MDI-Budesonide 160 mcg per Glycopyrronium 7.2 mcg per formoterol fumarate dehydrate 5.0 mcg with Aerosphere device , Tobramycin 300 mcg respules , Tab Garenoxacin 200 mg , Tab Feropenum sodium 200 mg plus potassium clavulanate 125 mg
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Indian Army
KOLKATA, WEST BENGAL
Indian Army
Indian Army
PATIALA, PUNJAB
Indian Army
DEHRADUN, UTTARAKHAND
Indian Army
PATIALA, PUNJAB
Tender Results
Loading results...
Rifampicin 600 mg plus Tab INH 300mg Tab
Rifampicin 600 mg+Tab INH 300mg Tab
Rifampicin 150mg Cap
Rifampicin 150mg Cap
Salmeterol 50 mcg plus fluticasone 250 mcg accuhaler of 60 doses
Salmeterol 50 mcg + fluticasone 250 mcg accuhaler of 60 doses
Symbicort Turbuhaler Budesonide 320 mcg plus formoterol 9ug
Symbicort Turbuhaler (Budesonide 320 mcg + formoterol 9ug)
Symbicort Turbuhaler Budesonide 160 mcg plus formoterol 4.5ug
Symbicort Turbuhaler Budesonide 160 mcg + formoterol 4.5ug)
RespiCaps Glycopyrronium Bromide USP equivalent to Glycopyrronium 25 mcg and Formoterol Fumarate Dihydrate IP equivalent to Formoterol Fumarate 12mcg and Excipients q.s
RespiCaps (Glycopyrronium Bromide USP equivalent to Glycopyrronium 25 mcg and Formoterol Fumarate Dihydrate IP equivalent to Formoterol Fumarate 12mcg and Excipients q.s)
Levosalbutamol Respules 0.31mg
Levosalbutamol Respules (0.31mg)
Budesonide 1 mg Respules.
Budesonide 1 mg Respules.
Tab Bilastin 20 mg plus montelukast 10 mg
Tab Bilastin 20 mg + montelukast 10 mg
Tab levonadifloxacin 500 mg
Tab levonadifloxacin 500 mg
Fluticasone Furoate 100 Mcg, Umeclidinium 62.5 Mcg and amp Vilanterol 25 mcg Inhaler Powder
Fluticasone Furoate 100 Mcg, Umeclidinium 62.5 Mcg and amp Vilanterol 25 mcg Inhaler Powder
INHALER CFC FREE with DOSE COUNTER MDI Glycopyrrolate IP 9.0mcg and Formoterol Fumarate 4.8mcg and Budesonide IP 160 mcg
INHALER CFC FREE with DOSE COUNTER MDI Glycopyrrolate IP 9.0mcg and Formoterol Fumarate 4.8mcg and Budesonide IP 160 mcg
Tab Montelukast 10 mg
Tab Montelukast 10 mg
Lignocaine HCl 2 percentage without Adrenaline 30 ml Inj suitable for ophthalmic use also
Lignocaine HCl 2%(without Adrenaline) 30 ml Inj (suitable for ophthalmic use also)
N-Acetyl Cysteine 200 mg per ml, 5 ml Ampoule
N-Acetyl Cysteine 200 mg/ml, 5 ml Ampoule
Urokinase 5 lacs unit plus diluent Inj
Urokinase 5 lacs unit + diluent Inj
MDI-Budesonide 160 mcg per Glycopyrronium 7.2 mcg per formoterol fumarate dehydrate 5.0 mcg with Aerosphere device
MDI-Budesonide 160 mcg/Glycopyrronium 7.2 mcg/formoterol fumarate dehydrate 5.0 mcg with Aerosphere device
Tobramycin 300 mcg respules
Tobramycin 300 mcg respules
Tab Garenoxacin 200 mg
Tab Garenoxacin 200 mg
Tab Feropenum sodium 200 mg plus potassium clavulanate 125 mg
Tab Feropenum sodium 200 mg + potassium clavulanate 125 mg
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Rifampicin 600 mg plus Tab INH 300mg Tab | Rifampicin 600 mg+Tab INH 300mg Tab | 9,200 | no | consignee2dglp | 30 | |
| 2 | Rifampicin 150mg Cap | Rifampicin 150mg Cap | 37,200 | no | consignee2dglp | 30 | |
| 3 | Salmeterol 50 mcg plus fluticasone 250 mcg accuhaler of 60 doses | Salmeterol 50 mcg + fluticasone 250 mcg accuhaler of 60 doses | 1,800 | no | consignee2dglp | 30 | |
| 4 | Symbicort Turbuhaler Budesonide 320 mcg plus formoterol 9ug | Symbicort Turbuhaler (Budesonide 320 mcg + formoterol 9ug) | 600 | no | consignee2dglp | 30 | |
| 5 | Symbicort Turbuhaler Budesonide 160 mcg plus formoterol 4.5ug | Symbicort Turbuhaler Budesonide 160 mcg + formoterol 4.5ug) | 600 | no | consignee2dglp | 30 | |
| 6 | RespiCaps Glycopyrronium Bromide USP equivalent to Glycopyrronium 25 mcg and Formoterol Fumarate Dihydrate IP equivalent to Formoterol Fumarate 12mcg and Excipients q.s | RespiCaps (Glycopyrronium Bromide USP equivalent to Glycopyrronium 25 mcg and Formoterol Fumarate Dihydrate IP equivalent to Formoterol Fumarate 12mcg and Excipients q.s) | 600 | no | consignee2dglp | 30 | |
| 7 | Levosalbutamol Respules 0.31mg | Levosalbutamol Respules (0.31mg) | 19,800 | no | consignee2dglp | 30 | |
| 8 | Budesonide 1 mg Respules. | Budesonide 1 mg Respules. | 36,000 | no | consignee2dglp | 30 | |
| 9 | Tab Bilastin 20 mg plus montelukast 10 mg | Tab Bilastin 20 mg + montelukast 10 mg | 13,200 | no | consignee2dglp | 30 | |
| 10 | Tab levonadifloxacin 500 mg | Tab levonadifloxacin 500 mg | 4,590 | no | consignee2dglp | 30 | |
| 11 | Fluticasone Furoate 100 Mcg, Umeclidinium 62.5 Mcg and amp Vilanterol 25 mcg Inhaler Powder | Fluticasone Furoate 100 Mcg, Umeclidinium 62.5 Mcg and amp Vilanterol 25 mcg Inhaler Powder | 900 | no | consignee2dglp | 30 | |
| 12 | INHALER CFC FREE with DOSE COUNTER MDI Glycopyrrolate IP 9.0mcg and Formoterol Fumarate 4.8mcg and Budesonide IP 160 mcg | INHALER CFC FREE with DOSE COUNTER MDI Glycopyrrolate IP 9.0mcg and Formoterol Fumarate 4.8mcg and Budesonide IP 160 mcg | 600 | no | consignee2dglp | 30 | |
| 13 | Tab Montelukast 10 mg | Tab Montelukast 10 mg | 48,000 | no | consignee2dglp | 30 | |
| 14 | Lignocaine HCl 2 percentage without Adrenaline 30 ml Inj suitable for ophthalmic use also | Lignocaine HCl 2%(without Adrenaline) 30 ml Inj (suitable for ophthalmic use also) | 4,090 | vial | consignee2dglp | 30 | |
| 15 | N-Acetyl Cysteine 200 mg per ml, 5 ml Ampoule | N-Acetyl Cysteine 200 mg/ml, 5 ml Ampoule | 2,900 | vial | consignee2dglp | 30 | |
| 16 | Urokinase 5 lacs unit plus diluent Inj | Urokinase 5 lacs unit + diluent Inj | 33 | amp or vial | consignee2dglp | 30 | |
| 17 | MDI-Budesonide 160 mcg per Glycopyrronium 7.2 mcg per formoterol fumarate dehydrate 5.0 mcg with Aerosphere device | MDI-Budesonide 160 mcg/Glycopyrronium 7.2 mcg/formoterol fumarate dehydrate 5.0 mcg with Aerosphere device | 1,200 | no | consignee2dglp | 30 | |
| 18 | Tobramycin 300 mcg respules | Tobramycin 300 mcg respules | 1,200 | respule | consignee2dglp | 30 | |
| 19 | Tab Garenoxacin 200 mg | Tab Garenoxacin 200 mg | 3,600 | no | consignee2dglp | 30 | |
| 20 | Tab Feropenum sodium 200 mg plus potassium clavulanate 125 mg | Tab Feropenum sodium 200 mg + potassium clavulanate 125 mg | 4,200 | no | consignee2dglp | 30 |
Discover companies most likely to bid on this tender
GST registration certificate
Permanent Account Number (PAN) card
OEM authorization certificates
Past performance / experience certificates
Financial statements (last 2 years)
EMD payment proof (₹5,605)
BBQR compliance brochure and schedules
Technical bid documents
Bidder turnover certificates
MII documents (if applicable)
Bidders must register on the GeM portal, submit BBQR-compliant brochures, OEM authorizations, EMD ₹5,605, and technical bids with past performance and turnover. Ensure shelf-life policies and indigenous product rules are followed; delivery terms align with last order date and 30+ days minimum extension.
Required documents include GST certificate, PAN, OEM authorization, financial statements, past performance records, EMD proof of ₹5,605, BBQR compliance brochure, and all technical bid documents. Ensure turnover and MII compliance documentation is present for evaluation.
Bidders must upload a comprehensive BBQR brochure and schedules; all items must comply with BBQR specifications; non-compliant quotes may be rejected; MII and OEM documents must accompany the bid; compliance verification is final.
The bid security amount is ₹5,605; it should be submitted as per BBQR terms via the prescribed payment mode and attached with the bid submission to avoid rejection.
The contract allows up to 50% variation in ordered quantity; delivery time is calculated from the last delivery order date with a minimum extension of 30 days; extended time scales with the ratio of increased to original quantity.
Indigenous drugs must have 5/6 of shelf life remaining; foreign products require 2/3 remaining at supply; stock replacement must occur before expiry and is subject to CFA/BBQR discretion.
The Technical Evaluation Committee at CFA/GeM review and decide on BBQR compliance, OEM authentication, past performance, and shelf-life adherence; their decision is final and binding for all vendors.
Dg Armed Forces Medical Service
📍 JAIPUR, RAJASTHAN
Indian Army
📍 NASHIK, MAHARASHTRA
Indian Army
Indian Air Force
📍 JAISALMER, RAJASTHAN
Indian Army
📍 PANCHKULA, HARYANA
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS